IGLL1

Green IGLL1 in COVID-19 research

Level 2: Viral research
Version 1.142

Sources

• IUIS Classification February 2018
• A- or hypo-gammaglobulinaemia v1.25
• London North GLH
• NHS GMS
• GRID V2.0
• Victorian Clinical Genetics Services
• North West GLH
• ESID Registry 20171117
• Expert Review Green
• NHS GMS
• North West GLH
• London North GLH
• Expert Review Green
• IUIS Classification February 2018
• Victorian Clinical Genetics Services
• ESID Registry 20171117
• GRID V2.0
• A- or hypo-gammaglobulinaemia v1.25

Phenotypes

• Agammaglobulinemia
• Severe bacterial infections, normal numbers of pro-B cells
• Agammaglobulinemia 2, 613500
• Agammaglobulinemia 2
• Predominantly Antibody Deficiencies

Green IGLL1 in Primary immunodeficiency or monogenic inflammatory bowel disease

Version 4.202
Latest signed off version: v4.0 (22 Mar 2023)

Sources

• NHS GMS
• North West GLH
• London North GLH
• Expert Review Green
• IUIS Classification February 2018
• Victorian Clinical Genetics Services
• ESID Registry 20171117
• GRID V2.0
• A- or hypo-gammaglobulinaemia v1.25

Phenotypes

• Agammaglobulinemia 2, 613500
• Agammaglobulinemia 2
• Agammaglobulinemia
• Severe bacterial infections, normal numbers of pro-B cells
• Predominantly Antibody Deficiencies

Green IGLL1 in Severe Paediatric Disorders

Version 1.184

Sources

• Next Generation Children Project
• Expert Review Green
• Expert list

Phenotypes

• Agammaglobulinemia 2, 613500